Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Arvinas Operations Inc.
Sponsor

Arvinas Operations Inc.

United States 5 Science Park, 06511-1966, United States

About the sponsor

Research activity includes advanced non-Hodgkin’s lymphoma and advanced solid tumors with KRAS G12D mutation, reflecting interest in hematologic and molecularly defined cancers.

  • Advanced Non-Hodgkin’s Lymphoma
  • KRAS G12D Mutated Advanced Solid Tumors
  • Advanced Cancer

These programs center on targeted oncology development in both blood cancers and mutation-selected solid malignancies.

About Specializations

Arvinas Operations Inc. runs clinical trials in conditions such as Neoplasm malignant, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Neoplasm malignant

Not yet recruiting

Study of ARV-6723 Alone or with Pembrolizumab to Assess Safety and Early Effect in Adults with Advanced Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Arvinas Operations Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.